Login / Signup

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.

Mark J GigantiKara W ChewJoseph J EronJonathan Z LiMauricio PinillaCarlee B MoserArzhang Cyrus JavanWilliam A FischerPaul KlekotkaDavid MargolisDavid Alain WohlRobert W CoombsEric S DaarDavey M SmithJudith S CurrierMichael D Hughesnull null
Published in: The Journal of infectious diseases (2023)
SARS-CoV-2 RNA levels are predictive of hospitalization/death in the natural history setting, but AN RNA levels may not be a reliable surrogate marker of mAb treatment effect in COVID-19 trials. Clinical Trials Registration. NCT04518410.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • clinical trial
  • coronavirus disease
  • randomized controlled trial
  • nucleic acid
  • chronic rhinosinusitis